Anonymous1 day ago
The return of measles to the United States — with over 2,280 cases in 2025 and more than 1,100 in just the first two months of 2026 — has generated an estimated $244 million in direct economic costs and counting. But the true toll, from immune amnesia that leaves survivors vulnerable for years, to fatal neurological complications that surface a decade later, to exhausted rural health departments diverting resources from other emergencies, defies any spreadsheet.